BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 28289584)

  • 1. Mutation analysis of the
    Onay H; Kacamak D; Kavasoglu AN; Akgun B; Yalcinli M; Kose S; Ozbaran B
    Balkan J Med Genet; 2016 Dec; 19(2):17-22. PubMed ID: 28289584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation screening of the neurexin 1 gene in thai patients with intellectual disability and autism spectrum disorder.
    Yangngam S; Plong-On O; Sripo T; Roongpraiwan R; Hansakunachai T; Wirojanan J; Sombuntham T; Ruangdaraganon N; Limprasert P
    Genet Test Mol Biomarkers; 2014 Jul; 18(7):510-5. PubMed ID: 24832020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of neurexin 1 associated with autism spectrum disorder.
    Kim HG; Kishikawa S; Higgins AW; Seong IS; Donovan DJ; Shen Y; Lally E; Weiss LA; Najm J; Kutsche K; Descartes M; Holt L; Braddock S; Troxell R; Kaplan L; Volkmar F; Klin A; Tsatsanis K; Harris DJ; Noens I; Pauls DL; Daly MJ; MacDonald ME; Morton CC; Quade BJ; Gusella JF
    Am J Hum Genet; 2008 Jan; 82(1):199-207. PubMed ID: 18179900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An increased burden of rare exonic variants in NRXN1 microdeletion carriers is likely to enhance the penetrance for autism spectrum disorder.
    Cameli C; Viggiano M; Rochat MJ; Maresca A; Caporali L; Fiorini C; Palombo F; Magini P; Duardo RC; Ceroni F; Scaduto MC; Posar A; Seri M; Carelli V; Visconti P; Bacchelli E; Maestrini E
    J Cell Mol Med; 2021 Mar; 25(5):2459-2470. PubMed ID: 33476483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Landscape of
    Cooper JN; Mittal J; Sangadi A; Klassen DL; King AM; Zalta M; Mittal R; Eshraghi AA
    J Clin Med; 2024 Apr; 13(7):. PubMed ID: 38610832
    [No Abstract]   [Full Text] [Related]  

  • 6. Functional characterization of rare NRXN1 variants identified in autism spectrum disorders and schizophrenia.
    Ishizuka K; Yoshida T; Kawabata T; Imai A; Mori H; Kimura H; Inada T; Okahisa Y; Egawa J; Usami M; Kushima I; Morikawa M; Okada T; Ikeda M; Branko A; Mori D; Someya T; Iwata N; Ozaki N
    J Neurodev Disord; 2020 Sep; 12(1):25. PubMed ID: 32942984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in NRXN1 in a family multiply affected with brain disorders: NRXN1 mutations and brain disorders.
    Duong L; Klitten LL; Møller RS; Ingason A; Jakobsen KD; Skjødt C; Didriksen M; Hjalgrim H; Werge T; Tommerup N
    Am J Med Genet B Neuropsychiatr Genet; 2012 Apr; 159B(3):354-8. PubMed ID: 22337556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare deletions at the neurexin 3 locus in autism spectrum disorder.
    Vaags AK; Lionel AC; Sato D; Goodenberger M; Stein QP; Curran S; Ogilvie C; Ahn JW; Drmic I; Senman L; Chrysler C; Thompson A; Russell C; Prasad A; Walker S; Pinto D; Marshall CR; Stavropoulos DJ; Zwaigenbaum L; Fernandez BA; Fombonne E; Bolton PF; Collier DA; Hodge JC; Roberts W; Szatmari P; Scherer SW
    Am J Hum Genet; 2012 Jan; 90(1):133-41. PubMed ID: 22209245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders.
    Ching MS; Shen Y; Tan WH; Jeste SS; Morrow EM; Chen X; Mukaddes NM; Yoo SY; Hanson E; Hundley R; Austin C; Becker RE; Berry GT; Driscoll K; Engle EC; Friedman S; Gusella JF; Hisama FM; Irons MB; Lafiosca T; LeClair E; Miller DT; Neessen M; Picker JD; Rappaport L; Rooney CM; Sarco DP; Stoler JM; Walsh CA; Wolff RR; Zhang T; Nasir RH; Wu BL;
    Am J Med Genet B Neuropsychiatr Genet; 2010 Jun; 153B(4):937-47. PubMed ID: 20468056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Neuropsychiatric Disease Modeling using Conditional Deletion Reveals Synaptic Transmission Defects Caused by Heterozygous Mutations in NRXN1.
    Pak C; Danko T; Zhang Y; Aoto J; Anderson G; Maxeiner S; Yi F; Wernig M; Südhof TC
    Cell Stem Cell; 2015 Sep; 17(3):316-28. PubMed ID: 26279266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable phenotype expression in a family segregating microdeletions of the
    Woodbury-Smith M; Nicolson R; Zarrei M; Yuen RKC; Walker S; Howe J; Uddin M; Hoang N; Buchanan JA; Chrysler C; Thompson A; Szatmari P; Scherer SW
    NPJ Genom Med; 2017 May; 2():. PubMed ID: 28649445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic spectrum of NRXN1 mono- and bi-allelic deficiency: A systematic review.
    Castronovo P; Baccarin M; Ricciardello A; Picinelli C; Tomaiuolo P; Cucinotta F; Frittoli M; Lintas C; Sacco R; Persico AM
    Clin Genet; 2020 Jan; 97(1):125-137. PubMed ID: 30873608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare NRXN1 missense variants identified in autism interfered protein degradation and Drosophila sleeping.
    Liu Y; Shen L; Zhang Y; Zhao R; Liu C; Luo S; Chen J; Xia L; Li T; Peng Y; Xia K
    J Psychiatr Res; 2021 Nov; 143():113-122. PubMed ID: 34487988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copy number and sequence variants implicate APBA2 as an autism candidate gene.
    Babatz TD; Kumar RA; Sudi J; Dobyns WB; Christian SL
    Autism Res; 2009 Dec; 2(6):359-64. PubMed ID: 20029827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NRXN1 deletion syndrome; phenotypic and penetrance data from 34 families.
    Al Shehhi M; Forman EB; Fitzgerald JE; McInerney V; Krawczyk J; Shen S; Betts DR; Ardle LM; Gorman KM; King MD; Green A; Gallagher L; Lynch SA
    Eur J Med Genet; 2019 Mar; 62(3):204-209. PubMed ID: 30031152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted massively parallel sequencing of autism spectrum disorder-associated genes in a case control cohort reveals rare loss-of-function risk variants.
    Griswold AJ; Dueker ND; Van Booven D; Rantus JA; Jaworski JM; Slifer SH; Schmidt MA; Hulme W; Konidari I; Whitehead PL; Cuccaro ML; Martin ER; Haines JL; Gilbert JR; Hussman JP; Pericak-Vance MA
    Mol Autism; 2015; 6():43. PubMed ID: 26185613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic contribution of Nrxn1α to autism-relevant behavioral phenotypes in mice.
    Xu B; Ho Y; Fasolino M; Medina J; O'Brien WT; Lamonica JM; Nugent E; Brodkin ES; Fuccillo MV; Bucan M; Zhou Z
    PLoS Genet; 2023 Feb; 19(2):e1010659. PubMed ID: 36848371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and clinical characterization of 25 individuals with exonic deletions of NRXN1 and comprehensive review of the literature.
    Béna F; Bruno DL; Eriksson M; van Ravenswaaij-Arts C; Stark Z; Dijkhuizen T; Gerkes E; Gimelli S; Ganesamoorthy D; Thuresson AC; Labalme A; Till M; Bilan F; Pasquier L; Kitzis A; Dubourgm C; Rossi M; Bottani A; Gagnebin M; Sanlaville D; Gilbert-Dussardier B; Guipponi M; van Haeringen A; Kriek M; Ruivenkamp C; Antonarakis SE; Anderlid BM; Slater HR; Schoumans J
    Am J Med Genet B Neuropsychiatr Genet; 2013 Jun; 162B(4):388-403. PubMed ID: 23533028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fraternal twins with autism, severe cognitive deficit, and epilepsy: diagnostic role of chromosomal microarray analysis.
    Imitola J; Walleigh D; Anderson CE; Jethva R; Carvalho KS; Legido A; Khurana DS
    Semin Pediatr Neurol; 2014 Jun; 21(2):167-71. PubMed ID: 25149956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational Saturation Mutagenesis to Investigate the Effects of Neurexin-1 Mutations on AlphaFold Structure.
    Rhoades R; Henry B; Prichett D; Fang Y; Teng S
    Genes (Basel); 2022 Apr; 13(5):. PubMed ID: 35627176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.